share_log

HC Wainwright & Co. Maintains Neutral on Co-Diagnostics, Lowers Price Target to $2.5

HC Wainwright & Co. Maintains Neutral on Co-Diagnostics, Lowers Price Target to $2.5

HC Wainwright & Co.对联合诊断保持中立,将目标股价下调至2.5美元
Moomoo 24/7 ·  03/15 06:49

HC Wainwright & Co. analyst Yi Chen maintains Co-Diagnostics (NASDAQ:CODX) with a Neutral and lowers the price target from $3 to $2.5.

HC Wainwright & Co. 分析师陈毅维持Co-Diagnostics(纳斯达克股票代码:CODX)的中性评级,并将目标股价从3美元下调至2.5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发